Your shopping cart is empty!
New research conducted by Yale University scientists is opening up new frontiers in the treatment of chronic pain. Certain compounds in cannabis have been found to have the ability to suppress pain signals without a psychoactive effect, making them a promising alternative to traditional painkillers, including opioids.
Chronic pain affects millions of people worldwide, reducing their quality of life and limiting their daily activities. Current treatments, including the use of opioids and other analgesics, carry serious risks. Key issues remain:
Finding safer and more effective alternatives is becoming a priority for modern medicine, and cannabinoids may be one of those solutions.
Researchers at the Yale School of Medicine conducted a series of experiments aimed at studying the effects of three key cannabinoids – cannabidiol (CBD), cannabigerol (CBG), and cannabinol (CBN) – on the mechanism of pain signal transmission. The focus was on the protein Nav1.8, which plays an important role in the activation of sensory neurons and the transmission of pain to the central nervous system.
Laboratory studies on rodent sensory neurons revealed:
Thus, cannabinoids represent a promising direction for the development of new pain-relieving drugs that are highly effective and have minimal risks.
The opioid crisis remains one of the most pressing health issues, especially in the United States, where over 80,000 drug-related deaths occur each year. The use of cannabinoids can help reduce opioid addiction by:
According to the study's authors, these discoveries could radically change the approach to chronic pain treatment and give patients the opportunity to receive effective treatment without the risk of addiction.
Dr. Stephen G. Waxman , professor of neurology at the Yale School of Medicine, notes:
"Our study demonstrates the potential of cannabinoids as a safe alternative for patients suffering from chronic pain. They can be used in conditions such as neuropathic pain, arthritis and inflammatory diseases, opening up new avenues for medicine."
In turn, the lead author of the study , Mohammad-Reza Ghovanloo, emphasizes the importance of CBG as the most promising compound:
“Of all the cannabinoids we studied, CBG showed the greatest potential to block pain signals without the side effects associated with traditional drugs.”
Further research in this area could lead to innovative cannabinoid-based drugs that could change the way we treat pain. The scientific community is already showing growing interest in these compounds, making them a promising alternative in the fight against chronic pain.
Vape attachment for CBD cartridge CCELL M3 Vape Pen Battery Standard 510 Thread (Black)This vape att..
CCELL Fino: Revolutionary Vaporizer with Magnetic Power DockThe CCELL Fino stands out from other vap..
Dark Chocolate with Salted Caramel Pearls 100mg CBD from Multitrance Dive into a world of de..
Discover a unique world of taste and well-being with Bubbly Billy Buds CBD lollipops . We present to..